The Medicines Company Wins Favorable Judgment In Angiomax® (Bivalirudin) Patent Litigation

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) announced the U.S. District Court for the Northern District of Illinois in The Medicines Company v. Mylan, Inc. entered judgment in favor of The Medicines Company on all issues concerning U.S. Patent No. 7,582,727 (the “’727 patent”). Following a June 2014 trial, Judge Amy St. Eve found all of the asserted claims (patent claims 1-3, 7-10, and 17) are infringed by Mylan’s Abbreviated New Drug Application (“ANDA”). The same claims were also found to be valid and enforceable.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC